Noninvasive prenatal exclusion of haemoglobin Bart's using foetal DNA from maternal plasma
Authors:
- 3 December 2009
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 30 (1) , 65-73
Abstract
Objective: Prenatal diagnosis of alpha‐thalassaemia requires invasive testing associated with a risk of miscarriage. Cell‐free foetal DNA in maternal plasma presents an alternative source of foetal genetic material for noninvasive prenatal diagnosis. We aimed to exclude HbBart's noninvasively by detection of unaffected paternal alleles in maternal plasma using quantitative fluorescence PCR (QF‐PCR).Method: Microsatellite markers (16PTEL05, 16PTEL06) within the breakpoint regions of ‐SEA, ‐FIL and ‐THAI deletions were analysed using QF‐PCR of maternal plasma from 30 families. In this blinded study, genotypes were confirmed using conventional PCR. Maternal plasma from two known cases of HbBart's were also analysed.Results: HbBart's was excluded in 10 out of 30 (33.3%, 95% CI, 17.3–52.8%) mothers by identifying the presence of nondeleted paternally inherited fetal alleles; either only 16PTEL05 (n = 1) or only 16PTEL06 (n = 4), or both (n = 5), and confirmed through direct analysis of fetal DNA. Paternally inherited foetal alleles of 16PTEL05 and 16PTEL06 were not detected in maternal plasma of the two known HbBarts cases. False negatives were excluded with the detection of paternally inherited fetal control marker, D21S1270 in maternal plasma.Conclusion: We show proof‐of‐principle that such a test can accurately exclude HbBart's in the foetus by identifying the nondeleted paternally inherited fetal alleles in maternal plasma in one out of three pregnancies, avoiding invasive testing in these pregnancies. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Medical Research Council (1084/2006)
This publication has 28 references indexed in Scilit:
- Prenatal diagnosis of hemoglobin Bart's disease caused by co‐inheritance of two different α0‐thalassemia defects in ChinaPrenatal Diagnosis, 2009
- Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasmaProceedings of the National Academy of Sciences, 2008
- Nonimmune Hydrops Fetalis Diagnosed during the Second Half of Pregnancy in Southern ChinaFetal Diagnosis and Therapy, 2007
- Development and Application of a Real‐Time Quantitative PCR for Prenatal Detection of Fetal α0‐Thalassemia from Maternal PlasmaAnnals of the New York Academy of Sciences, 2006
- Quantitation of fetal DNA in maternal serum during the first trimester of pregnancy by the use of a DAZ repetitive probeMolecular Human Reproduction, 2006
- Noninvasive genotyping of 9 Y‐chromosome specific STR loci using circulatory fetal DNA in maternal plasma by multiplex PCRPrenatal Diagnosis, 2006
- Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal DiagnosisThe American Journal of Human Genetics, 1998
- Prevalence of α-thalassemias in northern ThailandHuman Genetics, 1996
- Percutaneous Umbilical Blood Sampling: Indication Changes and Procedure Loss Rate in a Nine Years’ ExperienceFetal Diagnosis and Therapy, 1996
- RANDOMISED CONTROLLED TRIAL OF GENETIC AMNIOCENTESIS IN 4606 LOW-RISK WOMENThe Lancet, 1986